Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOvoca Bio Regulatory News (OVB)

  • There is currently no data for OVB

re: Norplat

25 Aug 2006 15:28

Ovoca Gold PLC25 August 2006 Ovoca Gold plc ('Ovoca' of the 'Company') OVOCA INCREASES SHAREHOLDING IN NORPLAT TO 100% Ovoca (AIM:OVG; IEX:OVX) announces that it has acquired 8,100,000 ordinaryshares in its subsidiary Norplat Limited ('Norplat'), under the terms of the May2005 Norplat Option Agreement, in consideration of the issue of 8,910,000 newOvoca ordinary shares of €0.025 each ('Ordinary Shares'). As a result of the transaction, Ovoca now has a 100% interest in Norplat. In addition, application will be made for 2,500,000 Ordinary Shares to be issuedto satisfy certain professional service and consultancy liability obligations. Roger Turner, Chairman, said "We are delighted to complete the acquisition ofNorplat, which is strategic to our long term plans. Exploration work has beencontinuing on Norplat's Kola Peninsula licences on gold and copper targets.Meanwhile, on the other side of Russia at our Goltsovoye silver project,drilling has commenced earlier this month as part of the bankable feasibilitystudy under the supervision of Wardell Armstrong International. Followingcompletion of the bankable study, Ovoca Gold plans to rapidly move into mineconstruction during 2008 and position the company to become a mid-tier preciousmetals producer." 25 August 2006 For further information please contact Roger Turner - Chairman+44 (0)7739 092 813 Tom McCormack - Connexions PR+ 353 (0)86 245 4215+ 353 (0)1 230 3015 Nick Bias - Buck Bias+44 (0)7887 920 530 John Frain - Davy Corporate Finance+ 353 (0)1 679 6363 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
5th Feb 20267:00 amRNSChange of Name
28th Jan 20268:00 amRNSReadmission - Ovoca Bio PLC
28th Jan 20267:00 amRNSFirst Day of Dealings on AIM
27th Jan 20262:32 pmRNSResult of Meeting
31st Dec 20258:00 amRNSSchedule One - Ovoca Bio Plc
31st Dec 20258:00 amRNSSchedule One - Ovoca Bio Plc
31st Dec 20257:00 amRNSNotice of AGM
31st Dec 20257:00 amRNSPublication of Admission Document
31st Dec 20257:00 amRNSPublication of Admission Document
31st Dec 20257:00 amRNSNotice of AGM
13th Nov 20257:00 amRNSChange of Broker
30th Sep 20251:09 pmRNSReplacement Half Year Report
30th Sep 20257:00 amRNSHalf-year Report
26th Jun 20257:00 amRNSPublication of 2024 Annual Report
5th Jun 20257:00 amRNSDelisting from Euronext Growth Exchange
7th May 20257:30 amRNSSuspension - Ovoca Bio plc
7th May 20257:00 amRNSProposed Acquisition, Disposal & Reverse Takeover
3rd Mar 20252:00 pmRNSManagement Changes
18th Dec 20246:00 pmRNSResult of AGM
18th Nov 20247:00 amRNSNotice of AGM
11th Oct 20245:30 pmRNSHolding(s) in Company
9th Oct 20245:45 pmRNSSale of Treasury Shares
25th Sep 20247:00 amRNSHalf-year Report
2nd Sep 20242:30 pmRNSConsultancy Agreement
15th Jul 20247:00 amRNSDirector/PDMR Shareholding
15th Jul 20247:00 amRNSDirectorate Change
28th Jun 20247:00 amRNSAnnual Financial Report
23rd Jan 20247:00 amRNSHolding(s) in Company
1st Dec 202312:00 pmRNSResult of AGM
7th Nov 20239:15 amRNSNotice of AGM
28th Sep 20237:00 amRNSInterim Results
31st Aug 20237:00 amRNSSummary Results of Phase II Study for Orenetide
30th Jun 20237:00 amRNSAnnual Financial Report
12th Jun 20237:00 amRNSUpdate on Completion Timelines for Phase II Study
16th Mar 20234:35 pmRNSPrice Monitoring Extension
16th Mar 20232:05 pmRNSSecond Price Monitoring Extn
16th Mar 20232:00 pmRNSPrice Monitoring Extension
16th Mar 20239:05 amRNSSecond Price Monitoring Extn
16th Mar 20239:00 amRNSPrice Monitoring Extension
8th Mar 20237:00 amRNSDisposal of Russian Assets
14th Feb 20234:41 pmRNSSecond Price Monitoring Extn
14th Feb 20234:35 pmRNSPrice Monitoring Extension
14th Feb 20232:05 pmRNSSecond Price Monitoring Extn
14th Feb 20232:00 pmRNSPrice Monitoring Extension
13th Feb 20239:00 amRNSPrice Monitoring Extension
13th Jan 202311:05 amRNSSecond Price Monitoring Extn
13th Jan 202311:00 amRNSPrice Monitoring Extension
28th Oct 20227:00 amRNSResult of AGM
6th Oct 20222:30 pmRNSNotice of AGM
30th Sep 20227:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.